| ASSET | MONTH | % RETURN |
|---|---|---|
Immunitybio (IBRX) | January 2020 | 65.01% |
Applied Blockchain (APLD) | January 2020 | 51.39% |
Apellis Pharmaceuticals (APLS) | January 2020 | 32.78% |
Appian (APPN) | January 2020 | 31.99% |
Denali Therapeutics (DNLI) | January 2020 | 31.89% |
Bill Com (BILL) | January 2020 | 31.18% |
TG Therapeutics (TGTX) | January 2020 | 27.9% |
Agilysys (AGYS) | January 2020 | 27.25% |
Tandem Diabetes Care (TNDM) | January 2020 | 27.07% |
Bath & Body Works (BBWI) | January 2020 | 26.9% |
WM Technology (MAPSW) | January 2020 | 25% |
iRhythm Technologies (IRTC) | January 2020 | 24.68% |
Impinj (PI) | January 2020 | 22.64% |
Goosehead Insurance (GSHD) | January 2020 | 22.43% |
Zai Lab (ZLAB) | January 2020 | 22.13% |
Sunrun (RUN) | January 2020 | 21.73% |
Ultragenyx (RARE) | January 2020 | 21.7% |
SLM (SLM) | January 2020 | 21.6% |
Soleno Therapeutics (SLNO) | January 2020 | 21.4% |
Ringcentral (RNG) | January 2020 | 20.93% |
Signet Jewelers (SIG) | January 2020 | 19.63% |
CLARIVATE (CLVT) | January 2020 | 19.57% |
Enphase Energy (ENPH) | January 2020 | 19.53% |
Ideaya Biosciences (IDYA) | January 2020 | 19.08% |
Appfolio (APPF) | January 2020 | 18.83% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
